Biotechnology Industry Organization

Based in DC

🤖

AI Overview

With $2.8M in lobbying spend across 35 quarterly filings, Biotechnology Industry Organization is a significant lobbying presence. They deploy 12 individual lobbyists Their lobbying covers 5 issue areas. Active from 2018 to 2025.

$2.8M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$320K
2019	$320K
2020	$320K
2021	$400K
2022	$400K
2023	$400K
2024	$320K
2025	$320K

Issues Lobbied

Taxation Budget/Appropriations Health Issues Medicare/Medicaid Pharmacy

Lobbying Firms

Tarplin, Downs & Young, LLC

Lobbyists

Raissa Downs Jennifer Young Michelle Easton Elizabeth Murray Charlotte Ivancic Pamela Smith Emily Murry Kimberly Brandt Margaret Joseph Peter Fise Laura Friedel Parick Carroll

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Budget/Appropriations, Health Issues, Medicare/Medicaid, Pharmacy

•pharmaceutical tax, orphan drug tax credit

•budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations
•H.R. 1625 - Consolidated Appropriations Act of 2018
•H.R. 1892 - Bipartisan Budget Act of 2018

•PL 114-255 - 21st Century Cures, implementation
•S. 456 - RACE for Children Act
•S. 771 - Improving Access to Affordable Prescription Drugs Act
•S. 637 - Creating Transparency to Have Drug Rebates Unlock

•Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference, health care reform, biosimilars, 340B, Sunshine, discount cards, MedPAC, coding, ASP, Part B, donut hole, P

•PL 114-255 - 21st Century Cures, implementation
•H.R. 2430 - FDA Reauthorization Act of 2017
•***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrit